Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Matthew S. Forsyth currently holds 23,171 shares of TransMedics Group, Inc. (TMDX), valued at approximately $0. This represents their equity stake as See Remarks.
Based on SEC Form 4 filings, Matthew S. Forsyth has been a net neutral trader of TMDX stock. They have purchased $0 and sold $0 worth of shares.
Matthew S. Forsyth's most recent insider trade was on May 19, 2026, when they sold 23,171 shares at $0.00 per share.
Matthew S. Forsyth serves as See Remarks at TransMedics Group, Inc. (TMDX). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Matthew S. Forsyth holds the position of See Remarks at TransMedics Group, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Matthew S. Forsyth has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Matthew S. Forsyth was on May 19, 2026, when they purchased $0 worth of TMDX shares. This transaction involved 23,171 shares at N/A per share.
Matthew S. Forsyth currently owns 23,171 shares of TransMedics Group, Inc. (TMDX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Matthew S. Forsyth's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Matthew S. Forsyth has 2 Form 4 filings on record as an insider at TransMedics Group, Inc..
Set alerts for Matthew S. Forsyth and 40,000+ other insiders.